Cargando…

Carboxypeptidase E Is a Novel Modulator of RANKL-Induced Osteoclast Differentiation

Osteoclasts are large polykaryons that have the unique capacity to degrade bone and are generated by the differentiation of myeloid lineage progenitors. To identify the genes involved in osteoclast development, we performed microarray analysis, and we found that carboxypeptidase E (CPE), a prohormon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun-Ju, Hong, JungMin, Yoon, Hye-Jin, Yoon, Young-Ran, Kim, Shin-Yoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179137/ https://www.ncbi.nlm.nih.gov/pubmed/25220258 http://dx.doi.org/10.14348/molcells.2014.0179

Ejemplares similares

A Medium-Chain Fatty Acid, Capric Acid, Inhibits RANKL-Induced Osteoclast Differentiation via the Suppression of NF-κB Signaling and Blocks Cytoskeletal Organization and Survival in Mature Osteoclasts
por: Kim, Hyun-Ju, et al.
Publicado: (2014)

Fucoidan, a Sulfated Polysaccharide, Inhibits Osteoclast Differentiation and Function by Modulating RANKL Signaling
por: Kim, Young Woo, et al.
Publicado: (2014)

Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption
por: Lim, Soomin, et al.
Publicado: (2023)

The estrogen-related receptor γ modulator, GSK5182, inhibits osteoclast differentiation and accelerates osteoclast apoptosis
por: Kim, Hyun-Ju, et al.
Publicado: (2021)

Effects of Melandrium firmum Rohrbach on RANKL-induced osteoclast differentiation and OVX rats
por: Kim, Minsun, et al.
Publicado: (2021)

Parthenolide inhibits osteoclast differentiation and bone resorbing activity by down-regulation of NFATc1 induction and c-Fos stability, during RANKL-mediated osteoclastogenesis
por: Kim, Ju-Young, et al.
Publicado: (2014)

Excessive osteoclast activation by osteoblast paracrine factor RANKL is a major cause of the abnormal long bone phenotype in Apert syndrome model mice
por: Shin, Hye‐Rim, et al.
Publicado: (2022)

The effects of Lycii Radicis Cortex on RANKL-induced osteoclast differentiation and activation in RAW 264.7 cells
por: KIM, JAE-HYUN, et al.
Publicado: (2016)

Signaling crosstalk between RANKL and interferons in osteoclast differentiation
por: Takayanagi, Hiroshi, et al.
Publicado: (2002)

Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption
por: Jang, Jin Sun, et al.
Publicado: (2019)

Magnolol Inhibits Osteoclast Differentiation via Suppression of RANKL Expression
por: Hwang, Youn-Hwan, et al.
Publicado: (2018)

Effects of Inositol 1,4,5-triphosphate on Osteoclast Differentiation in RANKL-induced Osteoclastogenesis
por: Son, Aran, et al.
Publicado: (2012)

Monosodium Urate in the Presence of RANKL Promotes Osteoclast Formation through Activation of c-Jun N-Terminal Kinase
por: Choe, Jung-Yoon, et al.
Publicado: (2015)

Spi-C positively regulates RANKL-mediated osteoclast differentiation and function
por: Go, Eun Mi, et al.
Publicado: (2020)

Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages
por: Choe, Jung-Yoon, et al.
Publicado: (2017)

Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis
por: Kim, Hyung Joon, et al.
Publicado: (2019)

Effect on Osteoclast Differentiation and ER Stress Downregulation by Amygdalin and RANKL Binding Interaction
por: Trang, Nguyen Minh, et al.
Publicado: (2022)

Obatoclax Regulates the Proliferation and Fusion of Osteoclast Precursors through the Inhibition of ERK Activation by RANKL
por: Oh, Ju Hee, et al.
Publicado: (2015)

β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways
por: Park, Gyeong Do, et al.
Publicado: (2021)

Plasma glutamate carboxypeptidase is a negative regulator in liver cancer metastasis
por: Lee, Jae-Hye, et al.
Publicado: (2016)

Effect of remifentanil on pre-osteoclast cell differentiation in vitro
por: Jeon, Hyun-Ook, et al.
Publicado: (2018)

Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation
por: Kim, Jung Young, et al.
Publicado: (2012)

CpG Oligodeoxynucleotides Inhibit RANKL-Induced Osteoclast Formation by Upregulating A20 Deubiquitinase in RAW 264.7 Cells
por: Kim, Seong-Kyu, et al.
Publicado: (2022)

Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation
por: Kim, Myoung Jun, et al.
Publicado: (2021)

Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation
por: Lee, Kyunghee, et al.
Publicado: (2016)

Serum amyloid A inhibits RANKL-induced osteoclast formation
por: Oh, Eunseo, et al.
Publicado: (2015)

Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression
por: Kim, Eun-Jung, et al.
Publicado: (2018)

Barley Seedling Extracts Inhibit RANKL-Induced Differentiation, Fusion, and Maturation of Osteoclasts in the Early-to-Late Stages of Osteoclastogenesis
por: Choi, Sik-Won, et al.
Publicado: (2017)

Oat Seedlings Extract Inhibits RANKL-Induced c-Fos/NFATc1 Transcription Factors in the Early Stage of Osteoclast Differentiation
por: Yang, Ji Yeong, et al.
Publicado: (2022)

Clathrin-dependent endocytosis of membrane-bound RANKL in differentiated osteoclasts
por: Narducci, P., et al.
Publicado: (2010)

Deficiency of Lipocalin-2 Promotes Proliferation and Differentiation of Osteoclast Precursors via Regulation of c-Fms Expression and Nuclear Factor-kappa B Activation
por: Kim, Hyun-Ju, et al.
Publicado: (2016)

Heme oxygenase-1 (HO-1)/carbon monoxide (CO) axis suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF-κB activation
por: Bak, Sun-Uk, et al.
Publicado: (2017)

Crataegus pinnatifida Bunge Inhibits RANKL-Induced Osteoclast Differentiation in RAW 264.7 Cells and Prevents Bone Loss in an Ovariectomized Rat Model
por: Kim, Minsun, et al.
Publicado: (2021)

MicroRNA-26a Regulates RANKL-Induced Osteoclast Formation
por: Kim, Kabsun, et al.
Publicado: (2015)

Inhibitory Effect of Cudratrixanthone U on RANKL-Induced Osteoclast Differentiation and Function in Macrophages and BMM Cells
por: Kim, Eun-Nam, et al.
Publicado: (2020)

Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1
por: Ibáñez, Lidia, et al.
Publicado: (2022)

Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway
por: Ihn, Hye Jung, et al.
Publicado: (2015)

Inhibitory Effect of Chrysanthemum zawadskii Herbich var. latilobum Kitamura Extract on RANKL-Induced Osteoclast Differentiation
por: Gu, Dong Ryun, et al.
Publicado: (2013)

Inhibitory Effects of Protopanaxadiol-Producing Transgenic Rice Seed Extracts on RANKL-Induced Osteoclast Differentiation
por: Lee, Yongjin, et al.
Publicado: (2022)

ELMO1 Regulates RANKL-Stimulated Differentiation and Bone Resorption of Osteoclasts
por: Liang, Xinyue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_knb86iupcginrdm3apr87ibkmo